Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Immunome Q1 EPS $(2.51) Misses $(0.69) Estimate, Sales $1.03M Miss $2.50M Estimate

Author: Benzinga Newsdesk | May 14, 2024 08:18am

Immunome (NASDAQ:IMNM) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate of $(0.69) by 263.77 percent. This is a 617.14 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $1.03 million which missed the analyst consensus estimate of $2.50 million by 58.84 percent. This is a 56.47 percent decrease over sales of $2.36 million the same period last year.

Posted In: IMNM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist